Go To Top
Who We Are

STAR TREE VENTURES IS AN ISRAEL-BASED BOUTIQUE BUSINESS DEVELOPMENT AND CORPORATE FINANCE ADVISORY THAT SPECIALIZES IN THE LIFE SCIENCES

We are the eyes and ears for global life science corporations, government bodies and investors looking to access the Israeli healthcare market, as well as for Israeli companies searching for diverse business opportunities around the globe, especially in the US, Europe, Asia and Latin America.

Our unparalleled ability to forge relationships between our global network of top biopharmaceutical and medical technology companies, world-class venture capitalists and the Israeli innovation ecosystem is at the heart of what we do. In building such relationships, we emphasize simplicity, seamlessness and discretion.

We seek to be a trusted, long-term partner of choice for our clients by offering them access to high-quality, proprietary deals.

Services

OUR PRACTICE IS FOUNDED
UPON EXPERIENCE AND
AN EXTENSIVE KNOWLEDGE
OF LIFE SCIENCES

We are experts at tailoring a solution for your investment and business development needs by identifying and vetting the very best technologies, entrepreneurs and in-licensing/M&A opportunities. We simplify the process and support you every step of the way until your goal is met.

Investments
M&A
Representation in Israel
Road-shows
Asset Search
Strategic Partnerships
Commercial / In-licensing / Sponsored research agreements / Joint ventures
Our Process and Competitive Advantage

WE PROVIDE OUR CLIENTS WITH HIGHLY PERSONALIZED SERVICE TO ENSURE THAT WE FIND THE RIGHT TOP TECHNOLOGIES FOR THEM

Our deep scientific background coupled with our expert knowledge of the Israeli innovation and healthcare industries provide us with unparalleled access to high-quality deals coming out of Israel’s leading innovators, developers, government agencies, R&D institutes, hospitals and incubator and accelerator programs.

Our team personally vets each and every party we work with so that only fitting connections based on mutual interest and benefit are made.

We will support you every step of the way, from introductory meetings through due diligence and negotiations to the moment the right deal is signed.

The nature of our work and the fields in which we operate require expert knowledge, privacy and trust at the highest level. We are dedicated to maintaining unimpeachable standards of honesty and transparency in everything we do and during every step of our work with you.

Team
Sharon Kaplinsky
CEO
Prof. Arie Orenstein, MD
Chief Medical Officer
Sharon Kaplinsky
CEO

Sharon is a leading specialist in international business development in the healthcare and technology industries.

Moved by the brilliantly innovative and resilient ability of Israeli start-ups to contribute to the world's most pressing challenges, Sharon was inspired to help accelerate the growth of Israeli technologies and connect them with the right partners and investors.

And Star Tree Ventures was born.

Prior to starting Star Tree, Sharon founded and managed business development and strategic planning for Orphan Technologies, Ltd., an Israeli company focused on researching and developing innovative therapies for rare, life-threatening diseases. In this role, she conducted due diligence on hundreds of early-stage healthcare products and identified and led in-licensing transactions.

Prior to that, Sharon was an associate consultant at Defined Health, a leading business development consulting company in New Jersey. In that capacity, she provided strategic advice, support and due diligence to leading global biopharmaceutical corporations that focused on the scientific, clinical, regulatory and commercial outlooks for their products.

She also served as a research analyst at Science and Technology Ventures, the technology transfer office of Columbia University.

Sharon has evaluated hundreds of therapeutic products in dozens of indications for biopharmaceutical companies as well as for leading healthcare investment funds.

She is a board member at Ramot, the technology transfer office of Tel Aviv University.

Sharon holds an M.A. in biotechnology from Columbia University and a B.Sc. summa cum laude in biology from Tel Aviv University, where she was a member of the Special Honors Research Program.

Prof. Arie Orenstein, MD
Chief Medical Officer

Professor Orenstein is board certified in plastic surgery and is the director of the Goldschleger Advanced Technology Center.

Professor Orenstein served as the chairman of the Sheba Medical Center Department of Plastic and Reconstructive Surgery and Burns for twenty years. In addition, Professor Orenstein served as co-chairman of the Israel Medical Association for twelve years, and he was the Israeli representative on the board of the World Medical Association for fifteen years.

Prof. Orenstein is an internationally recognized expert on the use of lasers in medicine, and in particular the clinical application of photodynamic therapy (PDT), an experimental method that uses light to cure skin cancer. While working both in Israel and abroad, he pioneered the use of novel laser systems and contributed to the understanding of the fundamental role of oxygen molecules in PDT.

He serves on the boards of Healthwatch, Hip Hope Technologies and Nova Sight and is a medical advisor to a number of Israeli companies.

You’re in Good Company

We’re privileged to be partners with some of the leading innovators from around the world, including the US, EU, Asia and Latin America.

Israel’s healthcare industry is world renowned for innovation, ingenuity and creativity
Life Science Companies
Digital Health Startups
Selected Companies in Our Portfolio
Multinational Companies R&D Centers
Raised by Israeli Startups in 2017
Interested in receiving updates on noteworthy business and investment opportunities?
STAY INFORMED WITH OUR NEWSLETTER
CONTACT US

Want to learn about innovations being developed in a specific area of interest,
or would you like to receive a quote for a project?

Call us any time
Or drop us a line

SAY HELLO